纳米体作为活生物疗法产品微生物学测试的潜在工具
Robert J Dorosky1, Jeremy E Schreier2, Stephanie L Lola3
1Office of Vaccines Research and Review, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. Robert.Dorosky@fda.hhs.gov.
AMB Express
|January 20, 2024
概括
研究人员开发了新的纳米体试剂,用于活生物疗法产品 (LBP) 功效测试. 这些特定的纳米体可以在复杂的混合物中区分和量化细菌菌株,推进LBP测试和临床研究.
科学领域:
- 生物技术是生物技术.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 含有多种细菌菌株的活生物治疗产品 (LBPs) 在实力测试中提出了挑战.
- 从驼类抗体中衍生出的纳米体,为标分子提供高特异性.
研究的目的:
- 开发和描述特定菌株的纳米体,用于活生物疗法产品 (LBP) 功效测试.
- 评估光标记纳米体在区分和量化LBP内的细菌菌株的实用性.
主要方法:
- 用Lactobacillus jensenii和L. crispatus全细胞对驼进行免疫接种.
- 一个纳米体菌体显示库的构建和调整.
- 使用诸如质谱,流细胞计和殖民地免疫血栓等技术表达,净化和表征纳米体.
主要成果:
- 确定了特定的纳米体 (Lj75,Lj94对于L. jensenii;Lc38,Lc58对于L. crispatus).
- 证明了对细菌物种的纳米体特异性,并确定了它们的蛋白质标 (酶和S层蛋白质).
- 光纳米体标签使LBP中混合细菌菌株的准确分化和量化成为可能.
结论:
- 开发了新的,针对菌株的纳米体试剂,用于LBP功效测试.
- 这些纳米体代表了LBP测试方法的重大进步.
- 有助于改善活生物治疗产品的临床研究和开发.
相关概念视频
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...


